AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 169 filers reported holding AXSOME THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.60 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $305,769 | -2.7% | 4,375 | 0.0% | 0.02% | 0.0% |
| Q2 2023 | $314,388 | +16.5% | 4,375 | 0.0% | 0.02% | +13.3% |
| Q1 2023 | $269,850 | -35.8% | 4,375 | -19.7% | 0.02% | -40.0% |
| Q4 2022 | $420,358 | +73.0% | 5,450 | 0.0% | 0.02% | +66.7% |
| Q3 2022 | $243,000 | +16.3% | 5,450 | 0.0% | 0.02% | +15.4% |
| Q2 2022 | $209,000 | -7.5% | 5,450 | 0.0% | 0.01% | +18.2% |
| Q1 2022 | $226,000 | +9.7% | 5,450 | 0.0% | 0.01% | +10.0% |
| Q4 2021 | $206,000 | +14.4% | 5,450 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $180,000 | -69.5% | 5,450 | -37.7% | 0.01% | -67.7% |
| Q2 2021 | $591,000 | +19.2% | 8,755 | 0.0% | 0.03% | +6.9% |
| Q1 2021 | $496,000 | -30.4% | 8,755 | 0.0% | 0.03% | -32.6% |
| Q4 2020 | $713,000 | +14.3% | 8,755 | 0.0% | 0.04% | 0.0% |
| Q3 2020 | $624,000 | -13.3% | 8,755 | 0.0% | 0.04% | -18.9% |
| Q2 2020 | $720,000 | +39.8% | 8,755 | 0.0% | 0.05% | +12.8% |
| Q1 2020 | $515,000 | -43.1% | 8,755 | 0.0% | 0.05% | -28.8% |
| Q4 2019 | $905,000 | +411.3% | 8,755 | 0.0% | 0.07% | +371.4% |
| Q3 2019 | $177,000 | -21.3% | 8,755 | 0.0% | 0.01% | -22.2% |
| Q2 2019 | $225,000 | +80.0% | 8,755 | 0.0% | 0.02% | +63.6% |
| Q1 2019 | $125,000 | +400.0% | 8,755 | 0.0% | 0.01% | +450.0% |
| Q4 2018 | $25,000 | -16.7% | 8,755 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $30,000 | +7.1% | 8,755 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $28,000 | +33.3% | 8,755 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $21,000 | -57.1% | 8,755 | 0.0% | 0.00% | -50.0% |
| Q4 2017 | $49,000 | 0.0% | 8,755 | 0.0% | 0.00% | -20.0% |
| Q3 2017 | $49,000 | +2.1% | 8,755 | 0.0% | 0.01% | 0.0% |
| Q2 2017 | $48,000 | +41.2% | 8,755 | 0.0% | 0.01% | +66.7% |
| Q1 2017 | $34,000 | -42.4% | 8,755 | 0.0% | 0.00% | -50.0% |
| Q4 2016 | $59,000 | – | 8,755 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 788,263 | $35,172,000 | 44.43% |
| Fairmount Funds Management LLC | 1,896,647 | $84,628,000 | 14.88% |
| ACT CAPITAL MANAGEMENT, LLC | 73,000 | $3,257,000 | 4.50% |
| Ghost Tree Capital, LLC | 300,000 | $13,386,000 | 3.76% |
| Ikarian Capital, LLC | 407,600 | $18,188,000 | 3.62% |
| Paradigm Biocapital Advisors LP | 520,080 | $23,206,000 | 3.09% |
| MORGAN JESS S & CO INC | 78,895 | $3,520,000 | 3.06% |
| PFM Health Sciences, LP | 1,659,733 | $74,057,000 | 2.68% |
| RTW INVESTMENTS, LP | 1,882,164 | $83,982,000 | 1.94% |
| Ghost Tree Capital, LLC | 150,000 | $6,693,000 | 1.88% |